Literature DB >> 3961819

Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate.

I M Bruggeman, J H Temmink, P J van Bladeren.   

Abstract

Ally isothiocyanate has been reported to be a bladder carcinogen in male rats. On the other hand, benzyl isothiocyanate is an anti-carcinogen. These contradicting properties led us to investigate the cytotoxicity of these compounds in RL-4 rat hepatocytes. Since conjugation with glutathione plays an important role in the metabolism of these isothiocyanates, the glutathione and L-cysteine derivatives were also tested for cytotoxicity (electron microscopy, trypan blue exclusion, cell attachment, and inhibition of cell division). Both types of conjugates caused considerable toxicity: allyl isothiocyanate conjugates gave effects comparable to the parent compound, but benzyl isothiocyanate was more toxic than its conjugates. Addition of excess glutathione (greater than 4mM) to the free isothiocyanates as well as their conjugates abolished cytotoxicity up to the highest concentration tested (250 microM). Addition of excess L-cysteine (5 to 20 mM) lowered the effects but did not abolish them. The reaction of thiols with isothiocyanates was readily reversible: 15 min after dissolving the conjugates in buffer, pH 7.4, an equilibrium was established in which 9 to 15% of the conjugates was converted to free isothiocyanate. Two hours after addition of 1 mM of the L-cysteine conjugates to medium containing 5 mM glutathione, 80% of the total conjugates was present as the glutathione derivatives. The glutathione conjugates were similarly converted to L-cysteine conjugates. Glutathione conjugates are not able to enter the cell, thus their toxicity is presumably due to the release of free isothiocyanate, and in the presence of excess glutathione no toxicity was observed. L-cysteine derivatives are able to cross the cell membrane, thus excess L-cysteine diminishes cytotoxicity, since less free isothiocyanate is present outside the cells, but does not completely protect the cells. Glutathione and cysteine can be regarded as transporting agents for the isothiocyanates through the body. Initial detoxification can be followed by release of the reactive compound at some other site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3961819     DOI: 10.1016/0041-008x(86)90312-1

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Cytomorphological changes in liver cells exposed to allyl and benzyl isothiocyanate and their cysteine and glutathione conjugates.

Authors:  J H Temmink; I M Bruggeman; P J van Bladeren
Journal:  Arch Toxicol       Date:  1986-07       Impact factor: 5.153

2.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

3.  The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.

Authors:  Arup Bhattacharya; Yun Li; Feng Geng; Rex Munday; Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2011-11-30       Impact factor: 4.944

Review 4.  The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates.

Authors:  Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2011-11-10       Impact factor: 4.944

Review 5.  The 1,2-benzenedithiole-based cyclocondensation assay: a valuable tool for the measurement of chemopreventive isothiocyanates.

Authors:  Yuesheng Zhang
Journal:  Crit Rev Food Sci Nutr       Date:  2012       Impact factor: 11.176

6.  Transthiocarbamoylation of proteins by thiolated isothiocyanates.

Authors:  Takahiro Shibata; Yuuki Kimura; Akihiro Mukai; Hitoshi Mori; Sohei Ito; Yukio Asaka; Sho Oe; Hiroshi Tanaka; Takashi Takahashi; Koji Uchida
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

7.  Inhibition of bladder cancer development by allyl isothiocyanate.

Authors:  Arup Bhattacharya; Li Tang; Yun Li; Feng Geng; Joseph D Paonessa; Shang Chiung Chen; Michael K K Wong; Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 8.  Allyl isothiocyanate as a cancer chemopreventive phytochemical.

Authors:  Yuesheng Zhang
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

9.  A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont.

Authors:  Catherine S Liou; Shannon J Sirk; Camil A C Diaz; Andrew P Klein; Curt R Fischer; Steven K Higginbottom; Amir Erez; Mohamed S Donia; Justin L Sonnenburg; Elizabeth S Sattely
Journal:  Cell       Date:  2020-02-20       Impact factor: 41.582

10.  Pharmacokinetics, Tissue Distribution, and Anti-Lipogenic/Adipogenic Effects of Allyl-Isothiocyanate Metabolites.

Authors:  Yang-Ji Kim; Da-Hye Lee; Jiyun Ahn; Woo-Jae Chung; Young Jin Jang; Ki-Seung Seong; Jae-Hak Moon; Tae Youl Ha; Chang Hwa Jung
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.